The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma bradykinin in angio-oedema
Nussberger, J., Cugno, M., Amstutz, C., Cicardi, M., Pellacani, A., & Agostoni, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09137-x · Cited by 706
Self-citation
Research works printed but not linked: 34
- Quincke, 1882, Über akutes umschriebenes Hautödem, Monatsh Prakt Dermatol, 1, 129
- Osler, 1888, Hereditary angioneurotic edema, Am J Med Sci, 95, 362, 10.1097/00000441-188804000-00004 · DOI · Paper page
- Tosi, 1998, Molecular genetics of C1 inhibitor, Immunobiology, 199, 358, 10.1016/S0171-2985(98)80040-5 · DOI
- Drouet, 2004, HAE: Mutation analysis of the C1INH gene, J Allergy Clin Immunol, 114, S66
- Bork, 2000, Hereditary angioedema with normal C1-inhibitor activity in women, Lancet, 356, 213, 10.1016/S0140-6736(00)02483-1 · DOI · Paper page
- Binkley, 2000, Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema, J Allergy Clin Immunol, 106, 546, 10.1067/mai.2000.108106 · DOI · Paper page
- Bork, 2006, Hereditary angioedema with normal C1 inhibitor in a family with affected women and men, Br J Dermatol, 154, 542, 10.1111/j.1365-2133.2005.07048.x · DOI
- Dewald, 2006, Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor, Biochem Biophys Res Commun, 343, 1286, 10.1016/j.bbrc.2006.03.092 · DOI · Paper page
- Bork, 2006, Hereditary angioedema due to C1 inhibitor deficiency: new findings concerning symptoms, affected organs, and course of disease, Am J Med, 119, 267, 10.1016/j.amjmed.2005.09.064 · DOI · Paper page
- Bork, 2006, Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency, Am J Gastroenterol, 101, 1, 10.1111/j.1572-0241.2006.00492.x · doi:10.1111/j.1572-0241.2006.00492.x
- Bork, 2003, Sudden upper airway obstruction in patients with hereditary angioedema, Tranfus Apheresis Sci, 29, 235, 10.1016/j.transci.2003.08.007 · DOI
- Bork, 2000, Asphyxiation by laryngeal edema in patients with hereditary angioedema, Mayo Clin Proc, 75, 349, 10.4065/75.4.349 · doi:10.4065/75.4.349
- Bork, 2003, Laryngeal edema and death from asphyxiation after tooth extraction in four patiens with hereditary angioedema, J Am Dent Assoc, 134, 1088, 10.14219/jada.archive.2003.0323 · DOI
- Nussberger, 2002, Bradykinin-mediated angioedema, N Engl J Med, 347, 621, 10.1056/NEJM200208223470820 · DOI · Paper page
- Nussberger, 1999, Local bradykinin generation in hereditary angioedema, J Allergy Clin Immunol, 104, 1321, 10.1016/S0091-6749(99)70030-8 · DOI · Paper page
- Han, 2002, Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor, J Clin Invest, 109, 1057, 10.1172/JCI200214211 · DOI
- Hock, 1991, Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies, Br J Pharmacol, 102, 769, 10.1111/j.1476-5381.1991.tb12248.x · DOI · Paper page
- Wirth, 1991, Hoe 140 a new potent and long acting bradykinin antagonist: in vivo studies, Br J Pharmacol, 102, 774, 10.1111/j.1476-5381.1991.tb12249.x · DOI · Paper page
- Cockcroft, 1994, Inhibition of bradykinin-induced vasodilation in human forearm vasculature by Icatibant, a potent B2-receptor antagonist, Br J Clin Pharmacol, 38, 317, 10.1111/j.1365-2125.1994.tb04360.x · DOI
- Todd, 1996, Clinical significance of reported changes in pain severity, Emerg Med, 27, 485
- Gallagher, 2002, Reliability and validity of a visual analog scale for acute abdominal pain in the ED, Am J Emerg Med, 20, 287, 10.1053/ajem.2002.33778 · DOI · Paper page
- Waytes, 1996, Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate, N Engl J Med, 334, 1630, 10.1056/NEJM199606203342503 · DOI · Paper page
- Altman, 1997, Statistics notes: units of analysis, BMJ, 314, 1874, 10.1136/bmj.314.7098.1874 · DOI · Paper page
- Bork, 2004, Current treatment of HAE and future treatment options, J Allergy Clin Immunol, 114, S94
- Bowen, 2004, Canadian 2003 International consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema, J Allergy Clin Immunol, 114, 629, 10.1016/j.jaci.2004.06.043 · DOI · Paper page
- Cicardi, 1997, Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients, J Allergy Clin Immunol, 99, 194, 10.1016/S0091-6749(97)70095-2 · DOI
- Bork, 1999, Hepatocellular adenomas in patients taking danazol for hereditary angiooedema, Lancet, 353, 1066, 10.1016/S0140-6736(99)00110-5 · doi:10.1016/s0140-6736(99)00110-5
- Bork, 2002, Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema, J Hepatol, 36, 707, 10.1016/S0168-8278(02)00035-1 · doi:10.1016/s0168-8278(02)00035-1
- Austin, 1994, Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage, Br J Pharmacol, 111, 969, 10.1111/j.1476-5381.1994.tb14835.x · DOI
- Turner, 2001, Role of kinins in seasonal allergic rhinitis: Icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen, J Allergy Clin Immunol, 107, 105, 10.1067/mai.2001.111145 · DOI
- Akbary, 1996, Efficacy and tolerability of Icatibant (Hoe 140) in patients with moderately severe chronic bronchial asthma, Immunopharmacology, 33, 238, 10.1016/0162-3109(96)00065-3 · DOI
- Gainer, 1998, Effect of bradykinin receptor blockade on the response to angiotensin converting enzyme inhibitor in normotensive and hypertensive human subjects, N Engl J Med, 339, 1285, 10.1056/NEJM199810293391804 · DOI · Paper page
- Squire, 2000, Bradykinin B (2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men, Hypertension, 36, 132, 10.1161/01.HYP.36.1.132 · doi:10.1161/01.hyp.36.1.132
- Kunschak, 1998, A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema, Transfusion, 38, 540, 10.1046/j.1537-2995.1998.38698326333.x · DOI
Cited by
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
Cicardi, M., Banerji, A., Bracho, F., Malbrán, A., Rosenkranz, B., Riedl, M., Bork, K., Lumry, W., Aberer, W., Bier, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906393 · Cited by 564
Self-citationMaurer, M., Magerl, M., Betschel, S., Aberer, W., Ansotegui, I. J., Aygören‐Pürsün, E., Banerji, A., Bara, N., Boccon‐Gibod, I., Bork, K., et al. (2022) · Allergy · doi:10.1111/all.15214 · Cited by 534
Self-citationMaurer, M., Magerl, M., Ansotegui, I., Aygören‐Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A. S., et al. (2018) · Allergy · doi:10.1111/all.13384 · Cited by 513
Self-citationCicardi, M., Bork, K., Caballero, T., Craig, T., Li, H. H., Longhurst, H., Reshef, A., Zuraw, B., & on behalf of HAWK (Hereditary Angioedema International Working Group) (2012) · Allergy · doi:10.1111/j.1398-9995.2011.02751.x · Cited by 349
Self-citationLonghurst, H., & Cicardi, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60935-5 · Cited by 330
Metadata
- Authors
- Bork, K., Frank, J., Grundt, B., Schlattmann, P., Nussberger, J., & Kreuz, W.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 119
- Issue
- 6
- Pages
- 1497-1503
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2136174251
- Cited by
- 200
- References
- 1
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). https://app.cochat.ai/papers/10.1016/j.jaci.2007.02.012
- The paper
- Bork, K., Frank, J., Grundt, B., Schlattmann, P., Nussberger, J., & Kreuz, W. (2007). Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2007.02.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.